PROCEPT BioRobotics Corporation (PRCT) Cash Flow Statement
PROCEPT BioRobotics Corporation (PRCT) generated -$74.3M of operating cash flow over the twelve months to 2026-06-30, spent $10.6M on capital expenditure and had free cash flow of -$84.9M, according to EquiReason's reading of its SEC filings.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
PRCTPROCEPT BioRobotics CorporationFollow PRCT — free
—
Price chart with a free account
- Market cap
- 1.1B
- P/E TTM
- —
- Dividend yield
- —
- 52-week
- —
- Next earnings
- 4 Nov, in 11 days
| Line | FY2021 Dec 21 | FY2022 Dec 22 | FY2023 Dec 23 | FY2024 Dec 24 | FY2025 Dec 25 | TTM Jun 26 | Trend |
|---|---|---|---|---|---|---|---|
| Operating cash flow | -57.3 | -80.4 | -108.0 | -99.2 | -49.0 | -74.3 | |
| Capital expenditure | 0.6 | 2.7 | 25.2 | 4.4 | 9.4 | -10.6 | |
| Free cash flow | -57.9 | -83.0 | -133.2 | -103.6 | -58.3 | -84.9 | |
| Stock-based compensation | 3.8 | 10.3 | 19.1 | 31.8 | 47.6 | — |
USD millions · SEC XBRL
PROCEPT BioRobotics Corporation — questions
- What is PROCEPT BioRobotics Corporation's operating cash flow?
- -$74.3M over the twelve months to 2026-06-30.
- How much does PROCEPT BioRobotics Corporation spend on capital expenditure?
- $10.6M over the twelve months to 2026-06-30.
- What is PROCEPT BioRobotics Corporation's free cash flow?
- -$84.9M over the twelve months to 2026-06-30: operating cash flow minus capital expenditure.
Every figure on this page comes from PROCEPT BioRobotics Corporation's own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.